NCT04062500 Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure
| NCT ID | NCT04062500 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai 10th People's Hospital |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,500 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2020-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,500 participants in total. It began in 2018-01-01 with a primary completion date of 2020-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.
Eligibility Criteria
Inclusion Criteria: \- 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines. 3\. Agree to be tested and sign an informed consent certificate. Exclusion Criteria: * 1\. Age\<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.
Contact & Investigator
Dachun Xu, PhD
PRINCIPAL INVESTIGATOR
Shanghai Tenthth People's Hospital
Frequently Asked Questions
Who can join the NCT04062500 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04062500 currently recruiting?
Yes, NCT04062500 is actively recruiting participants. Contact the research team at xdc77@tongji.edu.cn for enrollment information.
Where is the NCT04062500 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04062500 clinical trial?
NCT04062500 is sponsored by Shanghai 10th People's Hospital. The principal investigator is Dachun Xu, PhD at Shanghai Tenthth People's Hospital. The trial plans to enroll 10,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.